Fecal Microbiota Transplant for Children with Steroid-Resistant Gut GVHD
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests whether transplanting healthy gut bacteria can help children whose bodies are rejecting donor stem cells in their intestines and who haven't responded to high-dose steroids. The goal is to reduce intestinal damage and improve outcomes after bone marrow transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood or bone marrow disease (cancer or non-cancer) and received a stem cell transplant from a family member or unrelated donor
- You developed acute GVHD (graft-versus-host disease—your new immune system attacking your gut) that affects the intestines and hasn't improved despite high-dose steroids for at least 7 days
- Your intestinal GVHD is grade II or higher in severity
- You don't have active bacterial infections requiring ongoing antibiotics right now
- You don't have HIV, hepatitis C, or active hepatitis B infection
- You don't have severe mouth sores (mucositis) or a history of inflammatory bowel disease like Crohn's disease or ulcerative colitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help people with severe gut graft-versus-host disease that hasn't responded to steroids. It's for patients who have had a stem cell transplant and now have ongoing, severe gut symptoms.
This study tests whether restoring healthy gut bacteria using a fecal microbiota transplant can improve steroid-refractory gut graft-versus-host disease (aGvHD) after stem cell transplant. If your gut symptoms are your first episode and your stool bacteria diversity is low, this trial may be an option worth screening for.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
This Phase 1 study tests whether a fecal microbiota transplant (a stool-based treatment from a screened donor) plus a dietary fiber supplement can improve gut symptoms after a bone marrow transplant. It is aimed at people with mild to severe gut graft-versus-host disease (GVHD).
This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.
This trial studies a treatment made from donor gut microbes to help prevent a common complication after a transplant called acute graft-versus-host disease (aGVHD). It may help by improving the balance and variety of gut bacteria during recovery after haploidentical transplant.
Hear when a new Acute Graft Versus Host Disease in Intestine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.